Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions
Clinical Evaluation of the Modified VISTA Technique (M-VISTA )Using Albumin-platelet Rich Fibrin (Alb-PRF) Versus Connective Tissue Graft (CTG)in the Treatment of Multiple Miler Class III RT2 Recessions A Randomized Clinical Trial
1 other identifier
interventional
26
1 country
1
Brief Summary
treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2024
CompletedFirst Posted
Study publicly available on registry
October 16, 2024
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2027
March 20, 2026
March 1, 2026
1.7 years
October 10, 2024
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mean root coverage
primary outcome measures of mean root coverage in millimeters by UNC15 periodontal probe
6 months
Secondary Outcomes (6)
the percentage of mean root coverage
6 months
the percentage of complete root coverage
6 months
recession depth
6 months
recession width
6 months
keratinized tissue width
6 months
- +1 more secondary outcomes
Study Arms (2)
patients with gingival recession control group
ACTIVE COMPARATORpatients with gingival recessions of miller class III /RT2 the control group will be treated with modified vista technique using connective tissue graft
patients with gingival recession interventional group
EXPERIMENTALpatients with gingival recessions of miller class III /RT2 the interventional group will be treated with modified vista technique using albumin PRF
Interventions
Eligibility Criteria
You may qualify if:
- years old good oral hygiene
You may not qualify if:
- smokers patients with poor oral hygiene
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Dentistry Cairo University
Cairo, 4240101, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Enji EA Ahmed, BDS.MDS.PHD
Cairo University
- STUDY DIRECTOR
Sarah SE Elbanna, BDS.MDS.PHD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical evaluation of the modified VISTA technique (M-VISTA)using Albumin -platelet rich fibrin (Alb-PRF)versus connective tissue graft (CTG)in the treatment of multiple miller class III/RT2recessions : a randomized clinical trial
Study Record Dates
First Submitted
October 10, 2024
First Posted
October 16, 2024
Study Start
April 20, 2025
Primary Completion (Estimated)
December 20, 2026
Study Completion (Estimated)
January 30, 2027
Last Updated
March 20, 2026
Record last verified: 2026-03